Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation
90-day risk of CSDH recurrence may not differ between early and non-early resumption of anticoagulation, although early resumption could modestly accelerate recurrence. Allowing for the imprecision of the estimates, these findings provide important insights for clinical decision-making regarding anticoagulation resumption.
Authors
- Tomohiro Shinozaki (ORCID: https://orcid.org/0000-0003-3395-9691)
- Koji Kawakami (ORCID: https://orcid.org/0000-0002-7477-4071)
- Takayuki Anno (ORCID: https://orcid.org/0009-0000-7490-5820)
- Masato Takeuchi (ORCID: https://orcid.org/0000-0002-2990-2687)
- Toshiki Fukasawa (ORCID: https://orcid.org/0000-0001-7147-0737)
- Satomi Yoshida (ORCID: https://orcid.org/0000-0002-3411-9427)
Institutions
- University of Tsukuba (JP)
- Tokyo University of Science (JP)
- Kyoto University (JP)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1002/pds.70063
- Citations
- 10
- Primary Topic
- Neurosurgical Procedures and Complications
- Type
- article
- Field-Weighted Citation Impact
- 3.69